The Antiviral Drug Arbidol Inhibits Zika Virus
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-27224-4.pdf
Reference55 articles.
1. Aliota, M. T. et al. Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network. Antiviral Res 144, 223–246, https://doi.org/10.1016/j.antiviral.2017.06.001 (2017).
2. Medin, C. L. & Rothman, A. L. Zika Virus: The Agent and Its Biology, With Relevance to Pathology. Arch Pathol Lab Med 141, 33–42, https://doi.org/10.5858/arpa.2016-0409-RA (2017).
3. Boldescu, V., Behnam, M. A. M., Vasilakis, N. & Klein, C. D. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond. Nature reviews. Drug discovery 16, 565–586, https://doi.org/10.1038/nrd.2017.33 (2017).
4. Nayak, S., Lei, J., Pekosz, A., Klein, S. & Burd, I. Pathogenesis and Molecular Mechanisms of Zika Virus. Semin Reprod Med. https://doi.org/10.1055/s-0036-1592071 (2016).
5. Oehler, E. et al. Zika virus infection complicated by Guillain-Barre syndrome–case report, French Polynesia, December 2013. Euro Surveill 19 (2014).
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Computational insight of repurpose drug for treatment of COVID-19: a CDFT approach;Theoretical Chemistry Accounts;2023-12-27
2. Antiviral options and therapeutics against influenza: history, latest developments and future prospects;Frontiers in Cellular and Infection Microbiology;2023-11-29
3. The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs;mBio;2023-10-31
4. Multicenter, randomized controlled, open label evaluation of the efficacy and safety of arbidol hydrochloride tablets in the treatment of influenza-like cases;BMC Infectious Diseases;2023-09-06
5. Resveratrol Treatment-induced Nuclear HMGB1 Retention is Critical for Inducing Host Interferon Responses Against Zika Virus;The Natural Products Journal;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3